Sector Chart Celemics, Inc.

Stocks

A331920

KR7331920009

Biotechnology & Medical Research

End-of-day quote Korea S.E. 2026-09-22			5-day change	1st Jan Change
10,930.00 ^KRW	+0.64%		-14.54%	+302.58%

06-23	Celemics, Inc. announced that it expects to receive KRW 9.9999956 billion in funding from Cnp Co., Ltd.	CI
05-28	Celemics, Inc. announced that it has received KRW 11.5999945 billion in funding	CI

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes

Sector Other Biotechnology & Medical Research

	Capi.	Sales Growth	Profitability	Finances	EV / Sales	P/E
CELEMICS, INC.	88.33M	-	-	-	-	-
LONZA GROUP AG	46.68B
IQVIA HOLDINGS INC.	44.42B
REVOLUTION MEDICINES, INC.	41.32B	-	-	-	-	-
BEONE MEDICINES AG	41.58B
CELLTRION, INC.	30.14B